These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33804152)

  • 21. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of a celastrol derivative as a cancer stem cell inhibitor through regulation of the STAT3 pathway for treatment of ovarian cancer.
    Liu M; Li N; Wang Z; Wang S; Ren S; Li X
    RSC Med Chem; 2024 Aug; 15(10):3433-43. PubMed ID: 39246745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase.
    Butovich IA; Lukyanova SM; Bachmann C
    J Lipid Res; 2006 Nov; 47(11):2462-74. PubMed ID: 16899822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblasts promote the stemness of CD24
    Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
    J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells.
    Arnold KM; Opdenaker LM; Flynn NJ; Appeah DK; Sims-Mourtada J
    Int J Radiat Biol; 2020 Apr; 96(4):434-447. PubMed ID: 31850822
    [No Abstract]   [Full Text] [Related]  

  • 29. Limonin inhibits the stemness of cancer stem-like cells derived from colorectal carcinoma cells potentially
    Zhang WF; Ruan CW; Wu JB; Wu GL; Wang XG; Chen HJ
    World J Clin Oncol; 2024 Feb; 15(2):317-328. PubMed ID: 38455137
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Rios-Fuller TJ; Ortiz-Soto G; Lacourt-Ventura M; Maldonado-Martinez G; Cubano LA; Schneider RJ; Martinez-Montemayor MM
    Oncotarget; 2018 Nov; 9(89):35907-35921. PubMed ID: 30542507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in stemness properties associated with the heterogeneity of luminal-type breast cancer.
    Ito T; Sato N; Yamaguchi Y; Tazawa C; Moriya T; Hirakawa H; Hayashi S
    Clin Breast Cancer; 2015 Apr; 15(2):e93-103. PubMed ID: 25481840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells.
    Meng Y; Fan XY; Yang LJ; Xu BQ; He D; Xu Z; Wu D; Wang B; Cui HY; Wang SJ; Wang LJ; Wu XQ; Jiang JL; Xu L; Chen ZN; Li L
    Front Cell Dev Biol; 2020; 8():543856. PubMed ID: 33195186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PAK1-Stat3 Signaling Pathway Activates
    Kim JH; Choi HS; Kim SL; Lee DS
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation.
    Choi HS; Kim JH; Kim SL; Lee DS
    Cells; 2019 Aug; 8(9):. PubMed ID: 31480284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.
    Manandhar S; Kim CG; Lee SH; Kang SH; Basnet N; Lee YM
    Oncotarget; 2017 Sep; 8(41):70521-70537. PubMed ID: 29050299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.